Cannabis and Tourette Tics: Reading the Adult Meta-Analysis Carefully
A 2026 systematic review and meta-analysis reported lower tic and premonitory-urge scores with cannabis-based medicines in adult Tourette studies. The result is promising, but it should be read as a cautious adult evidence signal, not as a universal…
Monlunabant for Diabetic Kidney Disease: Why a Negative CB1 Trial Matters
A phase 2 randomized trial of monlunabant, a second-generation CB1 inverse agonist, did not establish proof of concept in diabetic kidney disease. The result is important because negative trials help separate cannabinoid-pathway promise from clinical…
Cannabis Edibles, Alcohol, and Driving: What the JAMA Trial Shows
A JAMA Network Open crossover trial found that cannabis edibles combined with alcohol worsened simulated driving and subjective intoxication more than either substance alone. The study also shows why common field-sobriety signals can miss meaningful…
High-Dose CBD Significantly Reduced Neuropathic Pain in Spinal Cord Injury: What a New RCT Reveals
A new randomized controlled trial shows high-dose CBD neuropathic pain spinal cord injury treatment significantly reduces chronic neuropathic pain intensity. This placebo-controlled study found that oral CBD up to 800 mg/day led to meaningful pain relief…
CED Cannabis Science Digest: 3 Withdrawal, Sleep, and Pediatric Exposure Signals
Three verified cannabis public-health signals on pediatric ingestions, opioid withdrawal self-management, and adolescent sleep-linked use, gathered in one evidence-aware digest.
CBN and CBD May Help Sleep. THC Does Not – And Now There Are Dosing Numbers.
A 2026 cannabis for insomnia meta-analysis finds CBD (50-300 mg) and CBN (20-100 mg) reduce sleep disturbance in adults with insomnia. THC formulations failed to outperform placebo and carried a higher adverse-effect burden. This evidence review covers…
Medical Cannabis for Chronic Pain: Function, Life Enjoyment, and Pain Scores
A new Minnesota medical cannabis study highlights medical cannabis chronic pain function by showing improvements in life enjoyment and daily activity. Many chronic pain patients report better function alongside pain score changes. This observational data…
CED Cannabis Science Digest: 3 Toxicology and Safety Signals Worth Watching
Three verified cannabis toxicology and safety signals on synthetic cannabinoids, emergency cardiovascular presentations, and laboratory immune effects, gathered in one evidence-aware digest.
Cannabinoids in Autism, Fragile X, and Rett: What a New Systematic Review Found
A new cannabinoids pediatric autism review examined cannabinoid-based products in autism, Fragile X syndrome, and Rett syndrome. The review found possible behavioral and seizure signals but the evidence remains limited. This systematic review highlights…
CED Cannabis Science Digest: 3 Surgery, Pregnancy, and Pain Signals Worth Watching
Three additional cannabis science signals on surgery outcomes, prenatal safety messaging, and early pain-delivery research, preserved with clear evidence limits.